Treatment of the TGF-β2-induced glaucoma model with Y27632 was shown to promote cytoskeleton reorganization and reduce the expression of both ECM and myocilin, indicating a potential interaction between the ROCK and TGF-β2 pathways [119]. The gene discussed is TGFB2; the disease is glaucoma.